Crinetics Pharmaceuticals (CRNX) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to -$19.7 million.
- Crinetics Pharmaceuticals' Other Gross PP&E Adjustments rose 2286.91% to -$19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.7 million, marking a year-over-year increase of 2286.91%. This contributed to the annual value of -$41.8 million for FY2024, which is 235.94% up from last year.
- Crinetics Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$19.7 million in Q3 2025, which was up 2286.91% from -$17.6 million recorded in Q2 2025.
- Crinetics Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $6.6 million for Q2 2023, and its period low was -$42.8 million during Q4 2023.
- Over the past 5 years, Crinetics Pharmaceuticals' median Other Gross PP&E Adjustments value was -$2.1 million (recorded in 2022), while the average stood at -$11.9 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 36051.23% in 2022, then crashed by 196797.1% in 2023.
- Over the past 5 years, Crinetics Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$1.5 million in 2021, then tumbled by 39.3% to -$2.1 million in 2022, then crashed by 1967.97% to -$42.8 million in 2023, then grew by 2.36% to -$41.8 million in 2024, then soared by 52.8% to -$19.7 million in 2025.
- Its last three reported values are -$19.7 million in Q3 2025, -$17.6 million for Q2 2025, and -$21.4 million during Q1 2025.